PROVECTUS BIOPHARMACEUTICALS's ticker is PVCTW and the CUSIP is 74373P116. A total of 3 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $1,000 | – | 2,960 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,200,000 | $440,000 | 0.07% |
| MILLENNIUM MANAGEMENT LLC | 500,000 | $100,000 | 0.00% |
| UBS Group AG | 425 | $0 | 0.00% |